Saxony's Minister-President Criticizes GlaxoSmithKline Over Dresden Site Closure
TL;DR
AI-generated
Saxony's Minister-President Michael Kretschmer sharply criticizes GlaxoSmithKline (GSK) for the planned closure of its Dresden site, affecting approximately 650 employees by summer 2027. He criticizes the announcement method and lack of efforts to establish new products there. GSK cites declining demand and overcapacity in flu vaccine production, which will be relocated to Canada.
Source: deutschlandfunk.de
Same event
- Pharma Industry - GSK to Close Vaccine Plant in Dresden
- Saxony's Minister-President Criticizes GlaxoSmithKline Over Dresden Site Closure
Discussion
Log in to join the discussion.
No comments yet. Be the first!